<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cold Spring Harb Perspect Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Cold Spring Harb Perspect Med</journal-id>
<journal-id journal-id-type="publisher-id">cshperspectmed</journal-id>
<journal-id journal-id-type="hwp">cshperspectmed</journal-id>
<journal-title-group>
<journal-title>Cold Spring Harbor Perspectives in Medicine</journal-title>
</journal-title-group>
<issn pub-type="epub">2157-1422</issn>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>
<publisher-loc>Cold Spring Harbor, New York</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28096241</article-id>
<article-id pub-id-type="pmc">5378010</article-id>
<article-id pub-id-type="doi">10.1101/cshperspect.a026450</article-id>
<article-id pub-id-type="publisher-id">a026450</article-id>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>116</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Perspectives</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Chromodomain Helicase DNA-Binding Chromatin Remodelers: Family Traits that Protect from and Promote Cancer</article-title>
<alt-title alt-title-type="left-running">A.A. Mills</alt-title>
<alt-title alt-title-type="right-running">CHD Chromatin Remodelers and Cancer</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mills</surname>
<given-names>Alea A.</given-names>
</name>
</contrib>
</contrib-group>
<aff>Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 11724</aff>
<author-notes>
<corresp>
<italic>Correspondence:</italic>
<email>mills@cshl.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>4</month>
<year>2017</year>
</pub-date>
<volume>7</volume>
<issue>4</issue>
<elocation-id>a026450</elocation-id>
<permissions>
<copyright-statement>
<ext-link ext-link-type="uri" xlink:href="http://www.perspectivesinmedicine.org/site/misc/terms.xhtml">Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved</ext-link>
</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="cshperspectmed-CCH-a026450.pdf"></self-uri>
<abstract>
<p>A plethora of mutations in chromatin regulators in diverse human cancers is emerging, attesting to the pivotal role of chromatin dynamics in tumorigenesis. A recurrent theme is inactivation of the chromodomain helicase DNA-binding (CHD) family of proteins—ATP-dependent chromatin remodelers that govern the cellular machinery’s access to DNA, thereby controlling fundamental processes, including transcription, proliferation, and DNA damage repair. This review highlights what is currently known about how genetic and epigenetic perturbation of CHD proteins and the pathways that they regulate set the stage for cancer, providing new insight for designing more effective anti-cancer therapies.</p>
</abstract>
<abstract abstract-type="precis">
<p>Chromodomain helicase DNA-binding (CHD) proteins control the access of cellular machinery to DNA. CHD subfamily II members are tumor suppressors; subfamilies I and III may suppress or promote tumorigenesis, depending on context.</p>
</abstract>
<counts>
<page-count count="15"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>